Bryn Mawr Capital Management LLC Purchases 908 Shares of Danaher Co. (NYSE:DHR)

Bryn Mawr Capital Management LLC boosted its position in shares of Danaher Co. (NYSE:DHR) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 73,314 shares of the conglomerate’s stock after buying an additional 908 shares during the period. Danaher makes up about 0.9% of Bryn Mawr Capital Management LLC’s portfolio, making the stock its 22nd biggest holding. Bryn Mawr Capital Management LLC’s holdings in Danaher were worth $16,829,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. FMR LLC lifted its holdings in shares of Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Danaher by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock worth $1,971,609,000 after buying an additional 441,012 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Danaher by 3.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock worth $1,417,342,000 after buying an additional 148,251 shares during the last quarter. Fisher Asset Management LLC raised its position in shares of Danaher by 2.6% during the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock valued at $1,265,725,000 after buying an additional 116,299 shares during the period. Finally, Flossbach Von Storch SE lifted its position in Danaher by 1.2% in the fourth quarter. Flossbach Von Storch SE now owns 3,710,738 shares of the conglomerate’s stock valued at $851,800,000 after buying an additional 44,490 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

DHR has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. The Goldman Sachs Group set a $250.00 price target on Danaher in a report on Wednesday, January 15th. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Finally, Jefferies Financial Group dropped their target price on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Price Performance

Shares of Danaher stock opened at $210.65 on Wednesday. The stock has a market capitalization of $150.56 billion, a price-to-earnings ratio of 39.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a fifty day moving average of $225.79 and a 200-day moving average of $246.04. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the company earned $2.09 earnings per share. Equities research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. Danaher’s dividend payout ratio (DPR) is presently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.